Explore More at wakehealth.edu


Biomarker Qualification Program

As part of an educational series on qualifying biomarkers for use in drug development, the FDA has released two fictitious examples of how biomarkers can improve the drug development process and how FDA works with researchers, pharmaceutical companies and patient advocates to qualify biomarkers.

Learn more about the Biomarker Qualification Program

All Announcements

Connect with the CTSI

Stay up-to-date on research news from the Wake Forest Clinical and Translational Science Institute. Subscribe now!